Sexual transmission of human T-lymphotropic virus type I (HTLV-I). 1989

E L Murphy, and J P Figueroa, and W N Gibbs, and A Brathwaite, and M Holding-Cobham, and D Waters, and B Cranston, and B Hanchard, and W A Blattner
National Cancer Institute, Bethesda, Maryland.

OBJECTIVE To study the seroprevalence of human T-lymphotropic virus type I (HTLV-I) in a sexually active population and to determine sexual behavior risk factors for infection. METHODS Cross-sectional seroprevalence study using enzyme-linked immunosorbent assay (ELISA) and Western blot. Risk-factor data were gathered by administered questionnaire and chart review. METHODS Two urban, primary care clinics for persons with sexually transmitted diseases run by the Jamaican Ministry of Health. METHODS Of the 2050 consecutive patients presenting with new episodes of sexually transmitted disease, 1977 patients were eligible for analysis. RESULTS Overall HTLV-I seroprevalence was 5.7%; prevalence increased with age from 1.6% (age, 14 to 19 years) to 5.1% (age, 30 years and older) in men and from 5.3% (age, 14 to 19 years) to 14.1% (age, 30 years and older) in women. Compared with a reference cohort of food service employees, age-adjusted HTLV-I seroprevalence was increased in female patients with sexually transmitted disease (odds ratio = 1.83; CI, 1.41 to 2.83) but not in male patients with sexually transmitted disease. Independent risk factors for HTLV-I infection in women included having had more than ten lifetime sexual partners (odds ratio = 3.52, CI, 1.28 to 9.69) and a current diagnosis of syphilis (odds ratio = 2.12; CI, 1.12 to 3.99). In men, a history of penile sores or ulcers (odds ratio = 2.13; CI, 1.05 to 4.33) and a current diagnosis of syphilis (odds ratio = 3.56; CI, 1.24 to 10.22) were independent risk factors for HTLV-I infection. Of 1977 patients, 5 (0.3%) had antibodies to human immunodeficiency virus type 1 (HIV-1), including 2 with HTLV-I and HIV-1 coinfection. CONCLUSIONS We conclude that HTLV-I is transmitted from infected men to women during sexual intercourse. Our data are consistent with the lower efficiency of female-to-male sexual transmission of HTLV-I, but penile ulcers or concurrent syphilis may increase a man's risk of infection.

UI MeSH Term Description Entries
D007563 Jamaica An island in the Greater Antilles in the West Indies. Its capital is Kingston. It was discovered in 1494 by Columbus and was a Spanish colony 1509-1655 until captured by the English. Its flourishing slave trade was abolished in the 19th century. It was a British colony 1655-1958 and a territory of the West Indies Federation 1958-62. It achieved full independence in 1962. The name is from the Arawak Xaymaca, rich in springs or land of springs. (From Webster's New Geographical Dictionary, 1988, p564 & Room, Brewer's Dictionary of Names, 1992, p267)
D008297 Male Males
D010409 Penile Diseases Pathological processes involving the PENIS or its component tissues. Penis Diseases,Disease, Penile,Disease, Penis,Diseases, Penile,Diseases, Penis,Penile Disease,Penis Disease
D012044 Regression Analysis Procedures for finding the mathematical function which best describes the relationship between a dependent variable and one or more independent variables. In linear regression (see LINEAR MODELS) the relationship is constrained to be a straight line and LEAST-SQUARES ANALYSIS is used to determine the best fit. In logistic regression (see LOGISTIC MODELS) the dependent variable is qualitative rather than continuously variable and LIKELIHOOD FUNCTIONS are used to find the best relationship. In multiple regression, the dependent variable is considered to depend on more than a single independent variable. Regression Diagnostics,Statistical Regression,Analysis, Regression,Analyses, Regression,Diagnostics, Regression,Regression Analyses,Regression, Statistical,Regressions, Statistical,Statistical Regressions
D003430 Cross-Sectional Studies Studies in which the presence or absence of disease or other health-related variables are determined in each member of the study population or in a representative sample at one particular time. This contrasts with LONGITUDINAL STUDIES which are followed over a period of time. Disease Frequency Surveys,Prevalence Studies,Analysis, Cross-Sectional,Cross Sectional Analysis,Cross-Sectional Survey,Surveys, Disease Frequency,Analyses, Cross Sectional,Analyses, Cross-Sectional,Analysis, Cross Sectional,Cross Sectional Analyses,Cross Sectional Studies,Cross Sectional Survey,Cross-Sectional Analyses,Cross-Sectional Analysis,Cross-Sectional Study,Cross-Sectional Surveys,Disease Frequency Survey,Prevalence Study,Studies, Cross-Sectional,Studies, Prevalence,Study, Cross-Sectional,Study, Prevalence,Survey, Cross-Sectional,Survey, Disease Frequency,Surveys, Cross-Sectional
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005260 Female Females
D006679 HIV Seropositivity Development of neutralizing antibodies in individuals who have been exposed to the human immunodeficiency virus (HIV/HTLV-III/LAV). AIDS Seroconversion,AIDS Seropositivity,Anti-HIV Positivity,HIV Antibody Positivity,HIV Seroconversion,HTLV-III Seroconversion,HTLV-III Seropositivity,AIDS Seroconversions,AIDS Seropositivities,Anti HIV Positivity,Anti-HIV Positivities,Antibody Positivities, HIV,Antibody Positivity, HIV,HIV Antibody Positivities,HIV Seroconversions,HIV Seropositivities,HTLV III Seroconversion,HTLV III Seropositivity,HTLV-III Seroconversions,HTLV-III Seropositivities,Positivities, Anti-HIV,Positivities, HIV Antibody,Positivity, Anti-HIV,Positivity, HIV Antibody,Seroconversion, AIDS,Seroconversion, HIV,Seroconversion, HTLV-III,Seroconversions, AIDS,Seroconversions, HIV,Seroconversions, HTLV-III,Seropositivities, AIDS,Seropositivities, HIV,Seropositivities, HTLV-III,Seropositivity, AIDS,Seropositivity, HIV,Seropositivity, HTLV-III
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

E L Murphy, and J P Figueroa, and W N Gibbs, and A Brathwaite, and M Holding-Cobham, and D Waters, and B Cranston, and B Hanchard, and W A Blattner
March 1996, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society,
E L Murphy, and J P Figueroa, and W N Gibbs, and A Brathwaite, and M Holding-Cobham, and D Waters, and B Cranston, and B Hanchard, and W A Blattner
June 2000, Presse medicale (Paris, France : 1983),
E L Murphy, and J P Figueroa, and W N Gibbs, and A Brathwaite, and M Holding-Cobham, and D Waters, and B Cranston, and B Hanchard, and W A Blattner
April 1994, Leukemia,
E L Murphy, and J P Figueroa, and W N Gibbs, and A Brathwaite, and M Holding-Cobham, and D Waters, and B Cranston, and B Hanchard, and W A Blattner
February 1990, Medicina clinica,
E L Murphy, and J P Figueroa, and W N Gibbs, and A Brathwaite, and M Holding-Cobham, and D Waters, and B Cranston, and B Hanchard, and W A Blattner
May 2005, The Journal of infectious diseases,
E L Murphy, and J P Figueroa, and W N Gibbs, and A Brathwaite, and M Holding-Cobham, and D Waters, and B Cranston, and B Hanchard, and W A Blattner
December 2000, Bone marrow transplantation,
E L Murphy, and J P Figueroa, and W N Gibbs, and A Brathwaite, and M Holding-Cobham, and D Waters, and B Cranston, and B Hanchard, and W A Blattner
September 1992, Journal of medical virology,
E L Murphy, and J P Figueroa, and W N Gibbs, and A Brathwaite, and M Holding-Cobham, and D Waters, and B Cranston, and B Hanchard, and W A Blattner
March 1995, Medicina clinica,
E L Murphy, and J P Figueroa, and W N Gibbs, and A Brathwaite, and M Holding-Cobham, and D Waters, and B Cranston, and B Hanchard, and W A Blattner
October 1991, Transfusion,
E L Murphy, and J P Figueroa, and W N Gibbs, and A Brathwaite, and M Holding-Cobham, and D Waters, and B Cranston, and B Hanchard, and W A Blattner
July 1994, The Journal of infectious diseases,
Copied contents to your clipboard!